Fellow of American College of Gastroenterology
American Board Certified in Gastroenterology and Hepatology in 11/2002
American Board Certified in Internal Medicine in 10/1998
02/2007 to present
President at AE & LY Medical Associates, PLLC with 50% practice in Hepatology
and 50% in Gastroenterology.
Former Director of Clinical Hepatology at Mount SinaiService at Elmhurst Hospital.
Voluntary teaching Hepatology Attending at Long Island Jewish Medical Center.
01/2003 to 02/2007
Medical Director at L & Y Medical Associates, P.C.
Director of Clinical Hepatology at Elmhurst Hospital, Mount Sinai
Service Voluntary teaching Hepatology Attending at Long Island Jewish Medical Center.
07/2001 to 12/2002
Staff Attending and Director of Hepatology in the Division of Gastroenterology and Hepatology at Long Island Jewish Medical Center, the Long Island Campus for the Albert Einstein College of Medicine, New York
07/1998 to 06/2001
Gastroenterology Fellowship Training at Long Island Jewish Medical Center with 12 months of Hepatology Fellowship training at the New Jersey Liver Center of the University of Medicine and Dentistry of New Jersey at Newark.
01/1998 to 05/1998
Internal Medicine Practice at the Health Center at the Champlain Valley Physician Hospital Medical Center at Plattsburgh, NY, an affiliated teaching hospital of Vermont Medical School.
01/1995 to 12/1997
Internal Medicine Residency Training at Long Island Jewish Medical Center
01/1993 to 12/1994
State University of New York Health Science Center at Syracuse, NY Doctor of Medicine
09/1986 to 06/1992
Sophie Davis School of Biomedical Education at the City University of New York
Bachelor of Science in Biomedical Education.
1997 Yao, A. Locke M, Stark B and Bank S. Case Report “Pancreatic
Calcification In An 18 Year Old Patient Following Gallstone
Pancreatitis and Recurrent Pseudocysts”. International Journal of Pancreatology, Oct 1997
2001 Co-Investigator at one of the local site in the clinical trial of “A Prospective, Randomized, Multicenter, Open-Label, Comparative Safety Study of Pegasys vs. Pegasys Plus Ribavirin Treatment vs. a Twelve-Week Treatment Delay in Patients with Chronic Hepatitis C”.
2001 Co-Investigator at one local site in the clinical trial of “An Efficacy And Safety Study of Intravenous Pantoprazole In The Prevention Of Recurrent Peptic Ulcer Bleeding After Successful Hemostasis”.
2001 Local Investigator in the clinical trial of “A Double-Blind, Placebo-Controlled Evaluation of Emtricitabine Once-Daily for the Treatment of Chronic Hepatitis B”.
2003 Seminar On “Current Treatment of Chronic Hepatitis B” was given at the Chinese-American Academic Professional Society Annual Meeting.
2004 Seminar On “Chronic Hepatitis B and Liver Cancer” was given at the American Cancer Society Liver Cancer Awareness Month.
2006 Organizer and Speaker of the three seminars conducted in the Flushing community, in the summer of 2006, on “Chronic Hepatitis B and Liver Cancer”. These events are sponsored by the American Cancer Society.
2007 Radio Station AM1480 interview on current issues of Chronic Hepatitis B and Chronic Hepatitis C on May 23, 2007.
2007 Guest Speaker on Chronic Hepatitis B and Liver Cancer. This seminar was given to the general audience on June 3, 2007 in an event to promote Hepatitis B awareness with screening and vaccination. The event was organized by American Cancer Society.
2007 Expert Panel discussion on New Treatment of Chronic Hepatitis B on June 2, 2007. The event was organized and sponsored by Indenix Pharmaceuticals.
2007 Expert Panel discussion on Updates in the Treatment and Challenges in Chronic Hepatitis B on June 19, 2007. The event was organized and sponsored by Gilead Pharmaceuticals.
2007 Guest Speaker on Treatment of Chronic Hepatitis B. This seminar was given to a group of 25 internists in Flushing, NY on June 21,
2007. The event was sponsor by the Roche Pharmaceuticals.
2007 Radio Station AM1480 interview on July 11, 2007 on Liver Cancerand Liver Transplant.
2008 Radio Station AM1480 interview on July 30, 2008 on Chronic HepatitisB and Liver Transplant.
2008 Community Speaker on Chronic Hepatitis B on behave of Novartis.
2008 Community Speaker on Chronic Hepatitis B on behave of Gilead.
2008 Community Speaker on Chronic Hepatitis C on behaved of Roche.
2008 ETTV television interview on September 26, 2008 on impact on chronic hepatitis B in the Asian American community
Board Certification in Internal Medicine – October 1998
New York State Medical License # 207115
Drug Enforcement Agency # 5480037
ECFMG Certification #0-468-233-2
February 2007 to Present
Vice President & Medical Director
AE & LY Medical Associates
Flushing, NY/Huntington, NY
June 2002 to February 2007
L & Y Medical Associates
Flushing, NY/Huntington, NY
December 1999 to May 2002
Plainview Internal Medicine
Group Internal Medicine practice with 20% inpatient
And 80% outpatient responsibility
July 1997 to November 1999
North Shore-LIJ Medical Care
East Meadow, NY
A satellite internal medicine office practice within the
North Shore-LIJ Health Care System
July 1994 to June 1997
St. Luke’s-Roosevelt Hospital Center
A University Hospital of Columbia University College Of Physician and Surgeons
New York, NY
Internal Medicine Residency
February 1994 to May 1994
Rancho Los Amigos Medical Center
An affiliated hospital of University of Southern California
Los Angeles, CA
Externship in diabetic care
March 1993 to December 1993
California pain Care Center –
Los Angeles, CA
September 1984 July 1990
Sun Yat-Sen University of Medical Sciences
One of the four best medical universities in China
Guangzhou, P.R. China
Doctor of Medicine
February 1987 – June 1997
The prevalence of EBV in General Population in the –
Southeast China and its Causal Relation to Nasopharyngeal Carcinoma
A Case Presentation and Review of the Literature
American College of Physician
Chinese American Medical Society